Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Time-restricted eating plus psychochrononutrition for people with metabolic syndrome

Official title: Effect of a Restricted Time and Psychochrononutritional Feeding Intervention Program on the Nutritional Status of People With Metabolic Syndrome in Ciudad Guzmán

Run by University of Guadalajara · NCT07389603 · Data updated 2026-11-12

This trial will test whether adding a psychochrononutritional program to time‑restricted eating helps adults with metabolic syndrome stick to the eating schedule and improve waist size, blood pressure, lipids, and blood sugar.

More Metabolic Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment64 (estimated)
SponsorUniversity of Guadalajara
Academic / other
Locations1 site (Ciudad Guzmán, Jalisco)
StatusRecruiting
StartedDecember 4, 2025
Main results expectedApril 2026
Study endsJune 2026
Registry record updatedFebruary 18, 2026
Trial IDNCT07389603 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–60 of either sex with a diagnosis of metabolic syndrome (meeting at least three NCEP criteria), a habitual feeding window of 14 hours or more, usual sleep duration over 6.5 hours, and ability to provide informed consent are ideal candidates.

Probably not a fit

People who are pregnant or breastfeeding, currently enrolled in a weight‑loss program, taking antidepressants or medications that alter glucose or appetite, on immunosuppressants, or otherwise excluded by protocol may not receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 64 adults aged 18–60 with metabolic syndrome in Ciudad Guzmán, Jalisco, and compare time‑restricted eating (a shortened daily feeding window) alone versus time‑restricted eating combined with a psychochrononutritional program that integrates psychological, chronobiological, and nutritional support. Participants will be randomized to one of the two intervention arms and followed for changes in adherence to the feeding window and metabolic measures that define metabolic syndrome. The study will collect anthropometric, blood pressure, and blood biomarker data to measure changes in waist circumference, triglycerides, HDL, fasting glucose, and blood pressure. The intervention aims to improve both behavioral adherence and metabolic outcomes through tailored counseling and timing-based nutritional guidance.

Why it matters

Potential benefit: If successful, the combined program could improve long‑term adherence to time‑restricted eating and reduce abdominal obesity, blood glucose, blood pressure, and triglycerides in people with metabolic syndrome.

How similar studies have gone: Previous trials of time‑restricted eating have shown promising improvements in glucose metabolism and abdominal obesity, but combining TRE with a formal psychochrononutritional behavioral program is a more novel approach with limited direct prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 60 years
* Both sexes
* Feeding window ≥14 h/day
* Usual sleep duration \>6.5 h
* Individuals diagnosed with metabolic syndrome who meet three or more of the criteria from Panel III of the National Cholesterol Education Program's Adult Treatment Guidelines:

  * Waist circumference: ≥102 cm for men, ≥88 cm for women
  * Triglycerides: ≥150 mg/dL or on treatment for hypertriglyceridemia
  * High-Density Lipoprotein (HDL) cholesterol: \<40 mg/dL for men, \<50 mg/dL for women
  * Blood pressure: systolic ≥130 mmHg and diastolic ≥85 mmHg or on treatment for hypertension
  * Fasting plasma glucose: ≥100 mg/dL
* Individuals who provide informed consent

Exclusion Criteria:

* (based on participant self-report unless medical records are available)

  * Pregnancy or lactation
  * Currently enrolled in a weight loss program
  * Current treatment with antidepressants, medications that affect glucose metabolism or appetite, or immunosuppressant therapy
  * History or presence of eating disorders
  * Sleep apnea

Elimination Criteria:

* Participants who do not attend more than two sessions of the psychochrononutritional intervention program.
* Participants who decide to withdraw their consent to continue in the study at any time for any reason.

Where it's running

  • Centro Universitario del Sur
    Ciudad Guzmán, Jalisco, Mexico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.